GCP
AGIO icon

GSA Capital Partners’s Agios Pharmaceuticals AGIO Stock Holding History

GSA Capital Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
+36,472
New +$1.03M 0.08% 370
2025
Q2 		– Sell
-41,029
Closed -$1.2M – 1710
2025
Q1 		$1.2M Sell
41,029
-12,200
-23% -$405K 0.11% 255
2024
Q4 		$1.75M Buy
+53,229
New +$2.5M 0.13% 123
2024
Q2 		– Sell
-30,853
Closed -$902K – 1590
2024
Q1 		$902K Sell
30,853
-73,262
-70% -$1.96M 0.07% 507
2023
Q4 		$2.32M Buy
+104,115
New +$2.33M 0.2% 79
2022
Q4 		– Sell
-8,986
Closed -$254K – 1413
2022
Q3 		$254K Buy
+8,986
New +$241K 0.03% 1040
2022
Q1 		– Sell
-58,059
Closed -$1.91M – 1370
2021
Q4 		$1.91M Buy
+58,059
New +$2.34M 0.24% 31
2020
Q4 		– Sell
-17,552
Closed -$614K – 1163
2020
Q3 		$614K Buy
+17,552
New +$769K 0.1% 286
2019
Q4 		– Sell
-11,764
Closed -$381K – 1403
2019
Q3 		$381K Buy
11,764
+4,236
+56% +$175K 0.05% 722
2019
Q2 		$375K Buy
+7,528
New +$402K 0.04% 847
2018
Q4 		– Sell
-3,400
Closed -$262K – 1310
2018
Q3 		$262K Buy
+3,400
New +$274K 0.01% 1386
2015
Q4 		– Sell
-3,134
Closed -$221K – 1788
2015
Q3 		$221K Sell
3,134
-7,600
-71% -$743K 0.01% 1525
2015
Q2 		$1.19M Sell
10,734
-20,633
-66% -$2.22M 0.05% 743
2015
Q1 		$2.96M Buy
+31,367
New +$3.51M 0.12% 170

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

GSA Capital Partners's AGIO Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2026: 36,472 shares worth $1.23M. The stake represents 0.08% of the portfolio and ranks #370 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in AGIO as recently as Q1 2025.

GSA Capital Partners first reported a position in AGIO in Q1 2015 and has held it in 14 quarters since. The position peaked at $2.96M in Q1 2015. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • GSA Capital Partners held 36,472 shares of Agios Pharmaceuticals worth $1.23M as of Q1 2026.
  • Agios Pharmaceuticals was a new GSA Capital Partners position in Q1 2026.
  • Agios Pharmaceuticals made up 0.08% of GSA Capital Partners's portfolio in Q1 2026, its #370 holding.
  • GSA Capital Partners first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 14 quarters since.
  • GSA Capital Partners's Agios Pharmaceuticals position peaked at $2.96M in Q1 2015.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.